Multiple sclerosis and Lyme borreliosis

Wiener Klinische Wochenschrift

Volumn 114, Issue 13-14, 2002, Pages 539-543

  Schmutzhard, Erich ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Multiple sclerosis; Neuroborreliosis; Progressive borrelial encephalomyelitis

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY;

BORRELIA INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DENDRITIC CELL; HUMAN; LYME DISEASE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SEROLOGY; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; NEUROLOGIC EXAMINATION; PREDICTION AND FORECASTING;

ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; COMPARATIVE STUDY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMAN; LYME DISEASE; LYME NEUROBORRELIOSIS; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; HUMANS;

EID: 0037205667     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Molecular mimicry and Lyme borreliosis: A shared antigenic determinant between Borrelia burgdorferi and human tissue
2. Progressive Borrelien-enzephalomyelitis. Chronische manifestation der erythema-chronicum-migrans-krankheit am nervensystem
3. Neuroopthalmic manifestations of Lyme disease
4. Spirochaetes and Lyme disease
5. Lyme borreliosis and multiple sclerosis: Any connection? A seroepidemic study
6. Borrelia burgdorferi antibodies in multiple sclerosis patients
7. Significance of reactive Lyme serology in multiple sclerosis
8. Childhood neuroborreliosis: Clinicoradiological correlation
9. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis
10. Multiple neurologic manifestations of Borrelia burgdorferi infection
11. MRI reveals pathology in neuro Lyme disease
12. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients
13. Multiple sclerosis or Lyme disease? A diagnosis problem of exclusion
14. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy
15. Spirochaetes, Lyme disease, and multiple sclerosis
16. Multiple sclerosis and its delineation from other diseases. Case report examples with differential diagnostic considerations
17. Neuroactive kynurenines in Lyme borreliosis
18. Central nervous system abnormalities in Lyme neuroborreliosis
19. Immunological differentiation between neuroborreliosis and multiple sclerosis
20. ELISA for specifying oligoclonal bands of isoelectric focusing of cerebrosspinal fluid in patients with neuroborreliosis and multiple sclerosis
21. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
22. Intrathecal immune response in patients with neuroborreliosis: Specificity of antibodies for neuronal proteins
23. Multiple sclerosis vs Lyme disease:A case presentation to a discussant and review of the literature
24. Relapsing fever/Lyme disease. Multiple sclerosis
25. Multiple sclerosis and positive Lyme serology
26. Multiple sclerosis and other related inflammatory disorders of the central nervous system: Differential diagnosis and treatment
27. Multiple sclerosis is a chronic central nervous system infection by a spirochetal agent
28. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease
29. Optic neuritis in children
30. The triad of neurologic manifestations of Lyme disease: Meningitis, cranial neuritis, and radiculoneuritis
31. Two subsets of dendritic cells are present in human cerebrospinal fluid
32. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures
33. Cerebrospinal fluid findings in neurological manifestations of Lyme disease
34. Cross-reactivity of Borrelia burgdorferi and myelin basic protein-specific T cells is not observed in borrelial encephalomyelitis
35. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases
36. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
37. Molecular mimicry: A critical look at exemplary instances in human disease
38. Optic neuropathy in children with Lyme disease
39. Lyme borreliosis and multiple sclerosis
40. Follow-up and sequelae in chronic neuroborreliosis
41. Lyme borreliosis and multiple sclerosis
42. Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis
43. Diseases that mimic multiple sclerosis
44. Lyme Disease
45. Dendritic cell development and maturation
46. Antimyelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases
47. Differential diagnosis of multiple sclerosis: Contribution of magnetic resonal techniques
48. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells
49. Chronic progressive neurological involvement in Borrelia burgdorferi infection
50. Practice guidelines for the treatment of Lyme disease
51. Infectious origins of, and molecular mimicry in Guillain-Barré and Fisher syndromes
52. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): Elevated levels are primarily related to CSF cell count